Status:
TERMINATED
Percutaneous Interventions in Adults With CHD
Lead Sponsor:
Children's Healthcare of Atlanta
Conditions:
Congenital Disorders
Eligibility:
All Genders
18+ years
Brief Summary
The primary objective of this study is to determine the clinical benefits of percutaneous intervention to improve pulmonary blood flow on oxygen saturations, symptoms, exercise tolerance and hematocri...
Detailed Description
This is a single center, retrospective study of adult patients with a diagnosis of un-repaired complex cyanotic congenital heart disease including Eisenmenger's Syndrome, single ventricle, pulmonary a...
Eligibility Criteria
Inclusion
- greater than 18 years of age
- complex cyanotic heart disease
- oxygen saturation prior to intervention \< 90%
Exclusion
- those who do not meet inclusion criteria
Key Trial Info
Start Date :
January 1 1996
Trial Type :
OBSERVATIONAL
End Date :
August 1 2006
Estimated Enrollment :
9 Patients enrolled
Trial Details
Trial ID
NCT00266916
Start Date
January 1 1996
End Date
August 1 2006
Last Update
May 23 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Healthcare of Atlanta
Atlanta, Georgia, United States, 30322